APrevent VOIS receives 2024 German NUB subsidy

APrevent VOIS, with its features of post-operative adjustment and standardized surgical procedures, effectively reduces the consumption of medical resources and provides high cost-effectiveness, has won the 2024 German New Medical Technology Additional Payment (NUB) subsidy.

2024-02-06

Partnership with Endotherapeutics Pty. Ltd. in Australia

Partnership with Endotherapeutics Pty. Ltd. in Australia

2023-11-23

VOIS TFDA Approval

VOIS TFDA Approval

2023-06-27

2023 ELS

2023 ELS

2023-06-26

APrevent signed distribution agreement with SPIGGLE & THEIS

APrevent signed distribution agreement with SPIGGLE & THEIS

2023-05-26

2023 ATLife

2023 ATLife

2023-04-17

Loading...